TATA Medical and Diagnostics or (TATA MD said it has received an order for 5 lakh OmiSure RT- PCR tests from Odisha State Medical Corporation Limited (OSMCL). TATA MD CHECK RT-PCR OmiSure, which is the only test approved by the Indian Council of Medical Research for RT-PCR detection of the Omicron variant, targets 3 genes with a single tube, fully multiplexed assay in a unique design that identifies simultaneous S-gene Target Failure (SGTF) and S-Gene Mutation Amplification (SGMA). Its confirmatory evaluation of RdRP target with internal controls leads to accurate diagnosis with significant reduction in the risk of false-positive reactions from contamination in control materials. 

The test, developed in partnership with ICMR for detection of the Omicron variant at the point of testing without the need for sequencing, will help the government to combat the Omicron spread within the state comparatively faster, said the company in a media statement.